Enanta Pharmaceuticals (ENTA) PT Raised to $67 at RBC Capital
Tweet
Share
E-mailGet Alerts ENTA Hot Sheet
Price: $12.79 -2.81%
Rating Summary:
15 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Rating Summary:
15 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams raised the price target on Enanta Pharmaceuticals (NASDAQ: ENTA) to $67.00 (from $64.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- argenx SE (ARGX) PT Raised to $1,353 at TD Cowen
- JD Logistics Inc (2618:HK) (JDLGF) PT Raised to HK$18.50 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
